RAS Peptide Profiles in Patients With Treatment-resistant Arterial Hypertension
NCT02962778 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2018-02-28
Summary
This study evaluates RAS peptides profiles in patients with treatment resistant arterial hypertension.
Conditions
Sponsors & Collaborators
-
University Hospital, Basel, Switzerland
lead OTHER
Principal Investigators
-
Manuel Haschke, MD, Dr. · Insel Gruppe AG, University Hospital Bern
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-10-31
- Primary Completion
- 2017-10-31
- Completion
- 2017-10-11
Countries
- Switzerland
Study Locations
More Related Trials
-
Renin-Angiotensin System Inhibitors and COVID-19
NCT04331574 ·Status: UNKNOWN
-
Use of Angiotensin-(1-7) in COVID-19
NCT04633772 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Predictive Role of Urinary Proteomics in Blood Pressure Response of Obese Hypertensive Treated With Irbesartan or Eplerenone.
NCT06208072 ·Status: RECRUITING ·Phase: NA
-
Renin-angiotensin-aldosterone System Polymorphisms in Resistant Hypertension and Adverse Cardiovascular Events
NCT01173029 ·Status: COMPLETED
-
National Survey on Hypertension at Hospital
NCT00695266 ·Status: COMPLETED
-
National Survey on Hypertension
NCT00804167 ·Status: COMPLETED
-
The Diagnosis and Treatment of Resistant Hypertension, the Prevalence and the Prognosis
NCT01703780 ·Status: UNKNOWN
-
Intensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hypertension IN Patients With Moderate to Severe Chronic Kidney Disease
NCT05732727 ·Status: RECRUITING ·Phase: PHASE3
-
Interrupters of VAscular daMAge in Malignant Hypertension
NCT04991077 ·Status: COMPLETED
-
The Effect of Sodium Nitrite on Renal Function and Blood Pressure in Hypertensive Versus Healthy Subjects
NCT02527837 ·Status: UNKNOWN ·Phase: PHASE1
-
Cardiovascular Effects of Angiotensin (1-7) in Essential Hypertension
NCT02245230 ·Status: TERMINATED ·Phase: PHASE1
-
Systemic Arterial Hypertension in Pediatric Age.
NCT06797908 ·Status: RECRUITING
-
Effects of Inhibition of NO-Synthesis on Renal Hemodynamics and Sodium Excretion in Patients With Essential Hypertension and Healthy Controls
NCT00345150 ·Status: COMPLETED ·Phase: PHASE1
-
B-type Natriuretic Peptide (BNP) in Human Hypertension
NCT00953472 ·Status: TERMINATED ·Phase: PHASE1
-
The Treatment of Hypertension Associated With Severe Preeclampsia (PE). A Trial of Urapidil Versus Nicardipine
NCT02558023 ·Status: TERMINATED ·Phase: PHASE3
-
RAS and Coagulopathy in COVID19
NCT04419610 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Evaluation of Target Organs Damage in Hypertensive Patients
NCT01055353 ·Status: COMPLETED
-
Pathophysiological Mechanisms of Hypertensive LVH:Optimising Regression
NCT00518479 ·Status: COMPLETED ·Phase: NA
-
Hypertension in Patients Hospitalized With COVID-19
NCT04318301 ·Status: COMPLETED
-
Pharmacogenomics of Hypertension Personalized Medicine (PGX-HT)
NCT03249285 ·Status: UNKNOWN ·Phase: PHASE3
-
Chymase Angiotensin-(1-12) Axis In Hypertensive Disease
NCT05644769 ·Status: UNKNOWN ·Phase: PHASE4
-
Evaluation of Lysine-Specific Demethylase 1
NCT01702688 ·Status: WITHDRAWN ·Phase: NA
-
Precision Treatment With Angiotensin Converting Enzyme Inhibitor
NCT05535595 ·Status: COMPLETED ·Phase: PHASE4
-
New Biomarkers and Difficult-to-treat Hypertension
NCT03034265 ·Status: COMPLETED
-
PRECISION-BP: Precision Chronopharamacotherapy Targeting NP-RAAS-BP Rhythm Axis
NCT04971720 ·Status: RECRUITING ·Phase: PHASE2/PHASE3